Skip to Content

Amiodarone Injection

Last Updated: January 6, 2018
Status: Current

Amiodarone Injection

Products Affected - Description
  • Nexterone injection, Baxter
    150 mg/100 mL, premixed bag, 12 count (NDC 43066-0150-10)
    360 mg/200 mL, premixed bag, 10 count (NDC 43066-0360-20)

    Amiodarone injection, Fresenius Kabi
    50 mg/mL, 9 mL vial, 10 count (NDC 63323-0616-09)

    Amiodarone injection, Mylan Institutional
    50 mg/mL, 9 mL vial, 10 count (NDC 67457-0153-09)
    50 mg/mL, 18 mL vial, 10 count (NDC 67457-0153-18)

Reason for the Shortage
    • Baxter has Nexterone premixed bags on shortage due to manufacturing delays.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Mylan Institutional did not provide a reason for the shortage.
Available Products
  • Amiodarone injection, Fresenius Kabi
    50 mg/mL, 3 mL vial, 10 count (NDC 63323-0616-03)

    Amiodarone injection, Mylan Institutional
    50 mg/mL, 3 mL vial, 10 count (NDC 67457-0153-03)

    Amiodarone injection, Sagent
    50 mg/mL, 3 mL syringe, 10 count (NDC 25021-0302-66)

    Amiodarone injection, West-Ward
    50 mg/mL, 3 mL vial, 10 count (NDC 00143-9875-10)

Estimated Resupply Dates

    • Baxter has Nexterone 150 mg/100 mL and 360 mg/200 mL premixed bags on back order and the company cannot estimate a release date.
    • Fresenius Kabi has amiodarone 50 mg/mL 9 mL vials in intermittent back order and the company is releasing product as it becomes available.
    • Mylan Institutional has amiodarone 50 mg/mL 9 mL vials on back order and the company estimates a release date of late-January 2018. The 18 mL vials are available with an expiration date of October 2018.

Updated

January 6, 2018, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide